Clinical trial: the efficacy and safety of oral PF‐03491390, a pancaspase inhibitor – a randomized placebo‐controlled study in patients with chronic hepatitis C von SHIFFMAN, M. L., POCKROS, P., MCHUTCHISON, J. G., SCHIFF, E. R., MORRIS, M., BURGESS, G.

Volltext

Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation von Degertekin, B., Han, Steven‐Huy B., Keeffe, E. B., Schiff, E. R., Luketic, V. A., Brown, Jr, R. S., Emre, S., Soldevila‐Pico, C., Reddy, K. R., Ishitani, M. B., Tran, T. T., Pruett, T. L., Lok, A. S. F.

Volltext

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease von Schiff, E. R., Frampton, M., Ben-Yosef, N., Avila, B. E., Semplici, F., Pontikos, N., Bloom, S. L., McCartney, S. A., Vega, R., Lovat, L. B., Wood, E., Hart, A., Israeli, E., Crespi, D., Furman, M. A., Mann, S., Murray, C. D., Segal, A. W., Levine, A. P.

Volltext

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States von Dienstag, Jules L, Schiff, Eugene R, Wright, Teresa L, Perrillo, Robert P, Hann, Hie-Won L, Goodman, Zachary, Crowther, Lynn, Condreay, Lynn D, Woessner, Mary, Rubin, Marc, Brown, Nathaniel A

Volltext

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C von McHutchison, John G, Gordon, Stuart C, Schiff, Eugene R, Shiffman, Mitchell L, Lee, William M, Rustgi, Vinod K, Goodman, Zachary D, Ling, Mei-Hsiu, Cort, Susannah, Albrecht, Janice K

Volltext

Hepatitis C and alcohol von Schiff, E R

Volltext

Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study von Bernstein, DE, Jeffers, L, Erhardtsen, E, Reddy, KR, Glazer, S, Squiban, P, Bech, R, Hedner, U, Schiff, ER

Volltext

A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection von Dienstag, Jules L, Perrillo, Robert P, Schiff, Eugene R, Bartholomew, Maria, Vicary, Catherine, Rubin, Marc

Volltext

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection von Tu, T., Mason, W. S., Clouston, A. D., Shackel, N. A., McCaughan, G. W., Yeh, M. M., Schiff, E. R., Ruszkiewicz, A. R., Chen, J. W., Harley, H. A. J., Stroeher, U. H., Jilbert, A. R.

Volltext

Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients von Westland, C. E., Yang, H., Delaney IV, W. E., Wulfsohn, M., Lama, N., Gibbs, C. S., Miller, M. D., Fry, J., Brosgart, C. L., Schiff, E. R., Xiong, S.

Volltext

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation von Bartholomew, Maria M, Jansen, Robert W, Jeffers, Lennox J, Reddy, K Rajender, Johnson, Lance C, Bunzendahl, Hartwig, Condreay, Lynn D, Tzakis, Andreas G, Schiff, Eugene R, Brown, Nathaniel A

Volltext

Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy von Dienstag, Jules L., Schiff, Eugene R., Mitchell, Mack, Casey, Donald E., Gitlin, Norman, Lissoos, Trevor, Gelb, Lawrence D., Condreay, Lynn, Crowther, Lynn, Rubin, Marc, Brown, Nathaniel

Volltext

Long-term clearance of hepatitis C virus following interferon [alpha]-2b or peginterferon [alpha]-2b, alone or in combination with ribavirin von Manns, M. P, Pockros, P. J, Norkrans, G, Smith, C. I, Morgan, T. R, Häussinger, D, Shiffman, M. L, Hadziyannis, S. J, Schmidt, W. N, Jacobson, I. M, Bárcena, R, Schiff, E. R, Shaikh, O. S, Bacon, B, Marcellin, P, Deng, W, Esteban-Mur, R, Poynard, T, Pedicone, L. D, Brass, C. A, Albrecht, J. K, Gordon, S. C

Volltext

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin von Manns, M. P., Pockros, P. J., Norkrans, G., Smith, C. I., Morgan, T. R., Häussinger, D., Shiffman, M. L., Hadziyannis, S. J., Schmidt, W. N., Jacobson, I. M., Bárcena, R., Schiff, E. R., Shaikh, O. S., Bacon, B., Marcellin, P., Deng, W., Esteban-Mur, R., Poynard, T., Pedicone, L. D., Brass, C. A., Albrecht, J. K., Gordon, S. C.

Volltext

Experience with staging laparoscopy in pancreatic malignancy von Reddy, K.Rajender, Levi, Joe, Livingstone, Alan, Jeffers, Lennox, Molina, Enrique, Kligerman, Seth, Bernstein, David, Kodali, Valli P., Schiff, Eugene R.

Volltext

Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency von Neff, G.W, Montalbano, M, Slapak-Green, G, Meyer, D, Berney, T, Safdar, K, Schiff, E.R, Tzakis, A.G

Volltext

Effect of Pretransplant Hepatitis C Virus RNA Status on Posttransplant Outcome von Nudo, C.G, Cortes, R.A, Weppler, D, Schiff, E.R, Tzakis, A.G, Regev, A

Volltext

Transient hepatopulmonary syndrome in a patient with acute hepatitis A von Regev, A, Yeshurun, M, Rodriguez, M, Sagie, A, Neff, G W, Molina, E G, Schiff, E R

Volltext

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C von Olynyk, John K., Reddy, K.Rajender, di Bisceglie, Adrian M., Jeffers, Lennox J., Parker, Talley I., Radick, Jason L., Schiff, Eugene R., Bacon, Bruce R.

Volltext

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C von Lindsay, Karen L., Trepo, Christian, Heintges, Tobias, Shiffman, Mitchell L., Gordon, Stuart C., Hoefs, John C., Schiff, Eugene R., Goodman, Zachary D., Laughlin, Mark, Yao, Ruji, Albrecht, Janice K.

Volltext